LoginRegister
    Ace Proxyvon Banned: Wockhardt moves Court against ban on Aceclofenac, Paracetamol, Rabeprazole ComboAce Proxyvon Banned: Wockhardt moves Court against ban on Aceclofenac, Paracetamol, Rabeprazole...
    NCLT allows Shivinder to withdraw plea against elder brother Malvinder SinghNCLT allows Shivinder to withdraw plea against elder brother Malvinder Singh
    Alembic Pharma gets USFDA nod for Alogliptin and Metformin tabletAlembic Pharma gets USFDA nod for Alogliptin and Metformin tablet
    USFDA completes inspection of Nagpur facility, no observation issued: LupinUSFDA completes inspection of Nagpur facility, no observation issued: Lupin
    Health Minsitry bans 328 FDC Banned Drugs, check out the complete listHealth Minsitry bans 328 FDC Banned Drugs, check out the complete list
    FDA approves AstraZeneca drug, Lumoxiti for a type of LeukaemiaFDA approves AstraZeneca drug, Lumoxiti for a type of Leukaemia
    EU investigating second impurity in ValsartanEU investigating second impurity in Valsartan
    FDC Ban Welcome, will rectify GRAVE situation of pharma market: AIDANFDC Ban Welcome, will rectify GRAVE situation of pharma market: AIDAN
    Zydus Cadila gets USFDA nod to market Risedronate drug to treat osteoporosisZydus Cadila gets USFDA nod to market Risedronate drug to treat osteoporosis
    Shivinder to withdraw petition in NCLT against elder brother Malvinder on mothers adviceShivinder to withdraw petition in NCLT against elder brother Malvinder on mother's advice
    Lets Promote Make In India: Orthopaedic Manufacturers Knock on PMs door for level playing fieldLets Promote Make In India: Orthopaedic Manufacturers Knock on PMs door for level playing field
    Lupin gets market approval of Atovaquone oral suspension By USFDALupin gets market approval of Atovaquone oral suspension By USFDA
    Medical Dialogues is health news portal designed to update medical and healthcare professionals but does not limit/block other interested parties from accessing our general health content. The health content on Medical Dialogues and its subdomains is created and/or edited by our expert team, that includes doctors, healthcare researchers and scientific writers, who review all medical information to keep them in line with the latest evidence-based medical information and accepted health guidelines by established medical organisations of the world.

    Any content/information on this website does not replace the advice of medical and/or health professionals and should not be construed as medical/diagnostic advice/endorsement or prescription.Use of this site is subject to our terms of use, privacy policy, advertisement policy. You can check out disclaimers here. © 2025 Minerva Medical Treatment Pvt Ltd

    © 2025 - Medical Dialogues. All Rights Reserved.
    Powered By: Hocalwire
    X